Patents by Inventor Hsuan-Yao Wang

Hsuan-Yao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INSULIN-TRANSFERRIN FUSION PROTEIN AND ITS PRODRUG, PROINSULIN-TRANSFERRIN, FOR OVERCOMING INSULIN RESISTANCE
    Publication number: 20220402993
    Abstract: A method of treating Type 2 diabetes (T2D) is provided. The method includes administering to a subject in need thereof an effective amount of a pharmaceutical composition that includes an insulin-transferrin fusion protein or its prodrug, proinsulin-transferrin fusion protein.
    Type: Application
    Filed: August 25, 2022
    Publication date: December 22, 2022
    Inventors: Wei-Chiang Shen, Yuqian Liu, Hsuan-Yao Wang
  • Insulin-transferrin fusion protein and its prodrug, proinsulin-transferrin, for overcoming insulin resistance
    Patent number: 11459368
    Abstract: A method of treating Type 2 diabetes (T2D) is provided. The method includes administering to a subject in need thereof an effective amount of a pharmaceutical composition that includes an insulin-transferrin fusion protein or its prodrug, proinsulin-transferrin fusion protein.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: October 4, 2022
    Assignee: Livactus, Inc.
    Inventors: Wei-Chiang Shen, Yuqian Liu, Hsuan-Yao Wang
  • INSULIN-TRANSFERRIN FUSION PROTEIN AND ITS PRODRUG, PROINSULIN-TRANSFERRIN, FOR OVERCOMING INSULIN RESISTANCE
    Publication number: 20200165315
    Abstract: A method of treating Type 2 diabetes (T2D) is provided. The method includes administering to a subject in need thereof an effective amount of a pharmaceutical composition that includes an insulin-transferrin fusion protein or its prodrug, proinsulin-transerrin fusion protein.
    Type: Application
    Filed: July 13, 2018
    Publication date: May 28, 2020
    Inventors: Wei-Chiang Shen, Yuqian Liu, Hsuan-Yao Wang